Peter Lu, Partner and Global Head of the China Practice at McDermott Will & Emery, discusses China’s opening of its health industry to international investors.
Dr Quinton Fivelman, PhD, Chief Scientific Officer at London Medical Laboratory, reveals that antibody levels for the double-jabbed are now waning. He asks was the UK Government unwise to relax most COVID precautions in July?.
Chris Lynch, Deputy CEO at Alzheimer’s Disease International, sheds light on the WHO Global action plan on the public health response to dementia 2017-2025.
A new editorial, published across 220 journals, expresses the climate concerns of healthcare professionals and researchers - with Dr Ghebreyesus saying "there is no vaccine for the climate crisis".
In a study spanning fifty years, researchers reveal that transgender people still face a disproportionate likelihood of death - a likelihood not connected to gender-affirming hormone treatment.
ONS data finds that young people are distrustful of the vaccine, the UK Government, and anyone encouraging vaccine take-up - alongside the perception that COVID will not threaten their lives.
The study, published in The Lancet Digital Health, found that deep learning tech had an average accuracy of 88% when it came to diagnosing genetic syndromes.
An ongoing real-world study on the Israeli population finds that the Pfizer COVID vaccine is safe to use - minimal side effects were observed in over 800,000 people.
A new study, published in The Lancet, found that 50% of hospitalised COVID patients have at least one symptom after 12 months - with one in three of them experiencing shortness of breath.
A study by Yale University, published in JAMA Psychiatry, says that suicidal thoughts in veterans remained stable throughout the isolation of the pandemic.
